1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
PAVmed Inc.

PAVmed Inc.

PAVM
PAVmed Inc.US flagNASDAQ Capital Market
6.00
USD
-0.15
- -
3.22MMarket Cap

Total Valuation

PAVmed Inc. carries a market capitalization of 3.22M, placing it among publicly traded companies globally. Its enterprise value stands at 9.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.22M
Enterprise Value9.49M

Share Statistics

PAVmed Inc. currently has 6.27M shares outstanding.

Shares Outstanding6.27M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PAVmed Inc. trades at a trailing price-to-earnings ratio of 0.11. The price-to-sales ratio is 114.34, and the price-to-book ratio stands at -0.04.

PE Ratio0.11
PS Ratio114.34
PB Ratio-0.04
P/TBV Ratio0.46
P/FCF Ratio-1.57
P/OCF Ratio-1.56

Enterprise Valuation

EV / Sales111.66
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

PAVmed Inc. maintains a current ratio of 2.02, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.07, indicating elevated leverage, while an interest coverage ratio of -1,187.45 demonstrates limited ability to service its debt obligations.

Current Ratio2.02
Quick Ratio1.77
Debt / Equity68.07
Debt / EBITDA-0.72
Interest Coverage-1,187.45

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-37.92
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.11

Stock Price Statistics

PAVmed Inc.'s stock has declined approximately -66.64869% over the past 52 weeks. The 50-day moving average sits at 8.16, while the 200-day moving average is 10.37.

Beta (5Y)N/A
52-Week Price Change-66.64869%
50-Day Moving Average8.16
200-Day Moving Average10.37
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, PAVmed Inc. generated 85,000.00 in revenue and converted that into -18.63M in net income, yielding earnings per share of -23.14. EBITDA reached -23.75M, while operating income came in at -23.83M.

Revenue85,000.00
Gross Profit-193,000.00
Operating Income-23.83M
Pretax Income-22.16M
Net Income-18.63M
EBITDA-23.75M
EBIT-23.83M
Earnings Per Share (EPS)-23.14

Balance Sheet

PAVmed Inc. holds 6.46M in cash and equivalents against 17.01M in total debt, resulting in a net debt position of 8.44M. Total book value stands at -259.02M, with working capital of 3.75M providing operational flexibility.

Cash & Cash Equivalents6.46M
Total Debt17.01M
Net Debt8.44M
Equity (Book Value)-259.02M
Book Value Per Share-270.52
Working Capital3.75M

Cash Flow

PAVmed Inc. produced -6.24M in operating cash flow over the past twelve months. After subtracting -47,000.00 in capital expenditures, free cash flow totaled -6.29M - equivalent to -6.57 per share.

Operating Cash Flow-6.24M
Capital Expenditures-47,000.00
Free Cash Flow-6.29M
FCF Per Share-6.57

Margins

PAVmed Inc. operates with a gross margin of -227.06, reflecting its pricing power and cost economics. The operating margin of -28,036.47 and net profit margin of -21,914.12 provide insight into operational efficiency.

Gross Margin-227.06
Operating Margin-28,036.47
Pretax Margin-26,065.88
Profit Margin-21,914.12
EBITDA Margin-27,940.00

Dividends & Yields

The company's payout ratio of 27.68 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio27.68
Shareholder Yield-103.43
FCF Yield-63.77

Stock Splits

PAVmed Inc.'s most recent stock split took place on January 2, 2026 with a 30:1 split ratio.

Last Split Date1/2/2026
Split Ratio30:1

Scores

PAVmed Inc. posts an Altman Z-Score of -9.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.33